Biotech Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Antares Pharma, Inc.
Gel reduces hot flashes in menopausal women
August 10th, 2005
Antares Pharma, Inc., (AIS) announced that its North American licensee, BioSante Pharmaceuticals, Inc., has announced significant phase III safety and efficacy results of bioidentical estradiol transdermal gel (Bio-E-Gel) for the treatment of moderate-to-severe hot flashes in menopausal women. A new drug application (NDA) is expected to be filed as soon as possible after completion of the data analysis, which is projected to be around the end of September. Bio-E-Gel utilizes Antares Pharma's proprietary Advanced Transdermal Delivery (ATD) gel system, which is designed to allow delivery of hormones and other active ingredients across the skin. Antares...
Source: Biotech Week (2005-08-10)
|
